BCBS Tennessee Medical Policy Updates – February 2019

Click here to view the Blue Cross Blue Shield Tennessee Medical Policy Updates »

February 2019 BCBS Tennessee Medical Policy Updates:

• Accelerated Partial Breast Irradiation and Brachytherapy Boost after Breast-Conserving Surgery for Early-Stage Breast Cancer
• Aldesleukin
• Alemtuzumab
• Aqueous Shunts and Stents for Glaucoma
• Atezolizumab
• Autonomic Nervous System Testing
• Axicabtagene Ciloleucel
• Azacitidine
• Bortezomib
• Bortezomib
• BRCA1, BRCA2 and PALB2 Testing for Breast, Ovarian and Other Cancers
• Browplasty
• Canakinumab
• Cemiplimab-rwlc
• Denosumab
• Eculizumab
• Eculizumab
• Emapalumab-lzsg
• Extracorporeal Shock Wave Therapy for Wounds
• Fecal Analysis in the Diagnosis of Intestinal Disorders
• Functional Neuromuscular Electrical Stimulation
• Genetic Testing (CFTR-mutations) for Cystic Fibrosis
• Human Papillomavirus (HPV) Vaccine
• Hyaluronan Derivatives for Intra-Articular Injection
• Intravenous Anesthetics for the Treatment of Chronic Pain
• Intravenous Immune Globulin (IVIG) Therapy
• Ipilimumab
• Lanadelumab-flyo
• Lanreotide
• Magnetic Resonance Imaging (MRI) of the Breast
• Mogamulizumab-kpkc
• Moxetumomab pasudotox-tdfk
• Neuromuscular Electrical Stimulation
• Omacetaxine Mepesuccinate
• Oscillating Devices for the Treatment of Respiratory Conditions
• Paclitaxel (Protein-Bound)
• Panitumumab
• Panitumumab
• Pasireotide Pamoate
• Patisiran
• Pembrolizumab
• Pemetrexed
• Percutaneous Vertebroplasty, Kyphoplasty and Sacroplasty
• Pneumatic Compression Pumps
• Pralatrexate
• Ravulizumab-cwvz
• Rituximab
• Rituximab-abbs
• Romiplostim
• Tagraxofusp-erzs
• Testosterone Pellets for Subcutaneous Implantation
• Tocilizumab (Intravenous)
• Trastuzumab
• Trastuzumab
• Trastuzumab
• Trastuzumab-dttb
• Trastuzumab-pkrb
• Triptorelin Extended-Release Injectable Suspension
• Urinary Tumor Markers for Bladder Cancer
• Vestronidase alfa-vjbk
• Ziv-Aflibercept

Click here to view the Blue Cross Blue Shield Tennessee Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.